基于网络药理学3种炭角菌科真菌代谢物谱的抗癌活性成分筛选OA
Screening of Anticancer Active Components of Three Species of Xylariaceae Fungi Metabolic Profiles Based on Network Pharmacology
为了从药用真菌资源中挖掘新型抗癌活性成分,基于炭角菌科Xylariaceae的紫褐炭角菌(Xylaria brunneovinosa,C3C)、痂状炭角菌(Xylaria escharoidea,A11)和蚁巢漆树霉(Geniculisynnema termiticola,A3)的LC-MS代谢物谱,结合多元统计分析与网络药理学方法,探究3种炭角菌的潜在抗癌活性成分.结果显示,3种炭角菌中共检测到1 093个物质,其中显著差异代谢物226个,无显著差异代谢物867个.从1 093个总代谢物中筛选出与癌症调控相关的21个药效成分,包括17个无显著差异成分和4个显著差异成分.本文重点分析了芒柄花素(FMN)、异牡荆素(IVI)、胡椒碱(PIP)及雷酚内酯(TPH)4个差异成分.FMN、IVI、PIP及TPH分别预测到105、77、35及19个药物作用靶点,这些靶点蛋白富集的信号通路主要与癌症、炎症、免疫系统等相关.分子对接分析表明,4个活性成分与核心靶点具有较强结合能力,FMN、IVI、PIP、TPH分别通过GLN147、SER17、LYS198、ARG82等位点与SRC、RAF1、CDK5、CHRM3等核心靶点结合,参与胃癌、乳腺癌、膀胱癌及神经退行性疾病的调控.CCK-8测定结果表明,3种炭角菌水提物和FMN、IVI、PIP、TPH对结直肠癌细胞株HCT-116均有显著抑制效果,A3菌株水提物的抑制活性相对最强(IC50值为44.80 μg/mL).研究结果为今后从价格低廉的真菌资源中筛选及研发新型抗癌药物提供了重要的理论依据和实验基础.
In order to explore new anticancer active ingredients from medicinal fungal resources,based on the LC-MS metabolite profiles of Xylaria brunneovinosa(C3C),Xylaria escharoidea(A11)and Geniculisynnema termiticola(A3)from Xylariaceae,combined with multivariate statistical analysis and network pharmacology methods,the potential anticancer active ingredients of two species of Xylaria and a related genus were explored.Three species of Xylariaceae were indentified.The results showed that a total of 1 093 metabolites were detected in the three species of Xylariaceae,of which 226 were significantly different and 867 were not significantly different.A total of 21 effective components related to cancer regulation were screened from 1 093 total metabolites,including 17 non-significant components and 4 significant differential components.This paper focuses on the analysis results of four differential components of formononetin(FMN),Isovitexin(IVI),Piperine(PIP)and Triptophenolide(TPH).A total of 105,77,35 and 19 drug targets were predicted by FMN,IVI,PIP and TPH,respectively.The signaling pathways enriched by these target proteins were mainly related to cancer,inflammation,immune system and so on.Molecular docking analysis showed that the four active components had strong binding ability with the core targets,FMN,IVI,PIP and TPH were combined with SRC,RAF1,CDK5,CHRM3 and other core targets through GLN147,SER17,LYS198,ARG82 and other sites,respectively,and were involved in the regulation of gastric cancer,breast cancer,bladder cancer and neurodegenerative diseases.The results of CCK-8 assay showed that the water extracts of three species of Xylariaceae and FMN,IVI,PIP,TPH had significant inhibitory effects on colorectal cancer cell line HCT-116,and the inhibitory activity of the water extracts of A3 was relatively strongest(IC50 value was 44.80 μg/mL).The results of this study provide an important theoretical basis and experimental basis for screening and developing new anticancer drugs from low-cost fungal resources in the future.
董杰;张实润;张曦予;王成凤;刘夏;刘佳艳;李宗菊
云南大学生命科学学院,昆明 650500云南大学生命科学学院,昆明 650500云南大学国际河流与生态安全研究院,昆明 650500云南大学生命科学学院,昆明 650500云南大学生命科学学院,昆明 650500云南大学生命科学学院,昆明 650500云南大学生态与环境学院,昆明 650500
农业科技
炭角菌科差异成分LC-MS网络药理抗癌活性成分
Xylariaceaedifferential metabolitesLC-MSnetwork pharmacologyanticancer ac-tive ingredients
《菌物研究》 2026 (4)
304-317,14
国家自然科学基金项目(31560575),云南省自然科学基金重点项目(2014FA020)
评论